OSR Health, Inc.

OSR Health, Inc. (Nasdaq: BLAC) filed an 8-K with the Securities and Exchange Commission on August 7, 2026, accession number 0001213900-26-086599, disclosing a material development at the healthcare-sector company. BLAC represents the surviving entity following the completion of a SPAC business combination, with the legacy blank-check vehicle having targeted the healthcare and life sciences space. The 8-K form signals a current reportable event under standard SEC disclosure requirements, making it a key document for investors and analysts monitoring post-combination SPAC issuers in the healthcare space. Sign up on SpacDesk for full data on BLAC, including deal timeline, sponsor background, and post-merger filing history.